Skip to main content
All lobbying firms

B HALL STRATEGIES, LLC

Registrant on federal lobbying filings · filed 2025 to 2026

$3,480,000 Income reported
21 Clients represented
133 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (401109669), not by name.

 Clients 21
 Lobbyists named 1
  • JAMES BRYANT HALL II 109 filings · through 2026 Staff Director, Sen. Veterans Affairs Committee (2003-2004); Legislative Director, Sen. Bob Graham (1999-2003).

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $1,740,000 61 filings
  • 2025 $1,740,000 72 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • SENATE 90
  • HOUSE OF REPRESENTATIVES 5
 Recent filings 133 total
Q3 report
TIBER CREEK GROUP OBO ABBVIE INC.
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $20,000 income · posted Oct 20, 2026
View →
Q3 report
VANTIVE US HEALTHCARE LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · $10,000 income · posted Oct 20, 2026
View →
Q3 reportNo activity
TIBER CREEK GROUP OBO MUSSALLEM CHD ALLIANCE
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP OBO SIEMENS HEALTHINEERS
3rd Quarter 2026 (July 1 - Sep 30) · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.
3rd Quarter 2026 (July 1 - Sep 30) · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP ON BEHALF OF MYRIAD GENETICS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 termination
TIBER CREEK HEALTH STRATEGIES, INC. OBO FRESENIUS MEDICAL CARE NORTH AMERICA
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 reportNo activity
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GRAIL, LLC
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $30,000 income · posted Oct 20, 2026
View →
Q3 report
TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA
3rd Quarter 2026 (July 1 - Sep 30) · Senate · $50,000 income · posted Oct 20, 2026
View →

Showing the 20 most recent of 133 filings. Search the explorer for "B HALL STRATEGIES, LLC".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem